US › Healthcare

111 Inc (YI)

US · Healthcare · Medical Distribution

$3.13+1.29%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$2.30B

Revenue YoY

-28.3%

Net profit

$-39.1M

EPS

$-0.60

Net margin

-1.7%

Key statistics

Market cap

$27.7M

P/E

0.3

Forward P/E

0.0

P/B

17.66

Book value

$-12.52

EPS (TTM)

$10.26

52-week high

$8.53

52-week low

$2.48

50-day MA

$3.52

200-day MA

$5.07

Beta

0.67

Analyst view

with an average price target of $5.96.

Shareholding

Insiders

28.56%

Institutions

0.66%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	0.20%
Renaissance Technologies Corp	0.15%
Serenus Wealth Advisors, LLC	0.05%
UBS Group AG	0.02%
SBI Securities Co Ltd	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
JPMorgan Chase & Co	0.00%
Rhumbline Advisers	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for 111 Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.